This week’s post reviews research published twenty-five years ago in Fertility and Sterility titled, “Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea,” and highlights the impact of naltrexone on the hypothalamic-pituitary-gonadal (HPG) axis and the possible association between the menstrual cycle and body weight. Dr. Maggie Musso summarized the research as a fourth-year medical student during the FACTS Elective offered through Georgetown University School of Medicine.
